Provided by Tiger Trade Technology Pte. Ltd.

Envoy Medical Inc.

0.7005
-0.0296-4.05%
Volume:16.72K
Turnover:11.89K
Market Cap:53.86M
PE:-0.92
High:0.7301
Open:0.7100
Low:0.7004
Close:0.7301
52wk High:1.89
52wk Low:0.3625
Shares:76.88M
Float Shares:38.12M
Volume Ratio:0.52
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7600
EPS(LYR):-1.2300
ROE:--
ROA:-86.53%
PB:14.58
PE(LYR):-0.57

Loading ...

Apr 30, 2024

Correspondence

Form CORRESP - Correspondence
Apr 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 05, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 18, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 18, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Oct 21, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Oct 05, 2023

Major Issues Report

Form 8-K - Current report
Oct 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 15, 2023

Major Issues Report

Form 8-K - Current report
Sep 15, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 14, 2023

Correspondence

Form CORRESP - Correspondence
Sep 13, 2023

Correspondence

Form CORRESP - Correspondence